Cargando…

No evidence for protective erythropoietin alpha signalling in rat hepatocytes

BACKGROUND: Recombinant human erythropoietin alpha (rHu-EPO) has been reported to protect the liver of rats and mice from ischemia-reperfusion injury. However, direct protective effects of rHu-EPO on hepatocytes and the responsible signalling pathways have not yet been described. The aim of the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramey, Thorsten, Freitag, Patricia, Fandrey, Joachim, Rauen, Ursula, Pamp, Katja, Erhard, Jochen, Frede, Stilla, de Groot, Herbert, Petrat, Frank
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678141/
https://www.ncbi.nlm.nih.gov/pubmed/19383129
http://dx.doi.org/10.1186/1471-230X-9-26
_version_ 1782166827337515008
author Bramey, Thorsten
Freitag, Patricia
Fandrey, Joachim
Rauen, Ursula
Pamp, Katja
Erhard, Jochen
Frede, Stilla
de Groot, Herbert
Petrat, Frank
author_facet Bramey, Thorsten
Freitag, Patricia
Fandrey, Joachim
Rauen, Ursula
Pamp, Katja
Erhard, Jochen
Frede, Stilla
de Groot, Herbert
Petrat, Frank
author_sort Bramey, Thorsten
collection PubMed
description BACKGROUND: Recombinant human erythropoietin alpha (rHu-EPO) has been reported to protect the liver of rats and mice from ischemia-reperfusion injury. However, direct protective effects of rHu-EPO on hepatocytes and the responsible signalling pathways have not yet been described. The aim of the present work was to study the protective effect of rHu-EPO on warm hypoxia-reoxygenation and cold-induced injury to hepatocytes and the rHu-EPO-dependent signalling involved. METHODS: Loss of viability of isolated rat hepatocytes subjected to hypoxia/reoxygenation or incubated at 4°C followed by rewarming was determined from released lactate dehydrogenase activity in the absence and presence of rHu-EPO (0.2–100 U/ml). Apoptotic nuclear morphology was assessed by fluorescence microscopy using the nuclear fluorophores H33342 and propidium iodide. Erythropoietin receptor (EPOR), EPO and Bcl-2 mRNAs were quantified by real time PCR. Activation of JAK-2, STAT-3 and STAT-5 in hepatocytes and rat livers perfused in situ was assessed by Western blotting. RESULTS: In contrast to previous in vivo studies on ischemia-reperfusion injury to the liver, rHu-EPO was without any protective effect on hypoxic injury, hypoxia-reoxygenation injury and cold-induced apoptosis to isolated cultured rat hepatocytes. EPOR mRNA was identified in these cells but specific detection of the EPO receptor protein was not possible due to the lack of antibody specificity. Both, in the cultured rat hepatocytes (10 U/ml for 15 minutes) and in the rat liver perfused in situ with rHu-EPO (8.9 U/ml for 15 minutes) no evidence for EPO-dependent signalling was found as indicated by missing effects of rHu-EPO on phosphorylation of JAK-2, STAT-3 and STAT-5 and on the induction of Bcl-2 mRNA. CONCLUSION: Together, these results indicate the absence of any protective EPO signalling in rat hepatocytes. This implies that the protection provided by rHu-EPO in vivo against ischemia-reperfusion and other causes of liver injury is most likely indirect and does not result from a direct effect on hepatocytes.
format Text
id pubmed-2678141
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26781412009-05-07 No evidence for protective erythropoietin alpha signalling in rat hepatocytes Bramey, Thorsten Freitag, Patricia Fandrey, Joachim Rauen, Ursula Pamp, Katja Erhard, Jochen Frede, Stilla de Groot, Herbert Petrat, Frank BMC Gastroenterol Research Article BACKGROUND: Recombinant human erythropoietin alpha (rHu-EPO) has been reported to protect the liver of rats and mice from ischemia-reperfusion injury. However, direct protective effects of rHu-EPO on hepatocytes and the responsible signalling pathways have not yet been described. The aim of the present work was to study the protective effect of rHu-EPO on warm hypoxia-reoxygenation and cold-induced injury to hepatocytes and the rHu-EPO-dependent signalling involved. METHODS: Loss of viability of isolated rat hepatocytes subjected to hypoxia/reoxygenation or incubated at 4°C followed by rewarming was determined from released lactate dehydrogenase activity in the absence and presence of rHu-EPO (0.2–100 U/ml). Apoptotic nuclear morphology was assessed by fluorescence microscopy using the nuclear fluorophores H33342 and propidium iodide. Erythropoietin receptor (EPOR), EPO and Bcl-2 mRNAs were quantified by real time PCR. Activation of JAK-2, STAT-3 and STAT-5 in hepatocytes and rat livers perfused in situ was assessed by Western blotting. RESULTS: In contrast to previous in vivo studies on ischemia-reperfusion injury to the liver, rHu-EPO was without any protective effect on hypoxic injury, hypoxia-reoxygenation injury and cold-induced apoptosis to isolated cultured rat hepatocytes. EPOR mRNA was identified in these cells but specific detection of the EPO receptor protein was not possible due to the lack of antibody specificity. Both, in the cultured rat hepatocytes (10 U/ml for 15 minutes) and in the rat liver perfused in situ with rHu-EPO (8.9 U/ml for 15 minutes) no evidence for EPO-dependent signalling was found as indicated by missing effects of rHu-EPO on phosphorylation of JAK-2, STAT-3 and STAT-5 and on the induction of Bcl-2 mRNA. CONCLUSION: Together, these results indicate the absence of any protective EPO signalling in rat hepatocytes. This implies that the protection provided by rHu-EPO in vivo against ischemia-reperfusion and other causes of liver injury is most likely indirect and does not result from a direct effect on hepatocytes. BioMed Central 2009-04-21 /pmc/articles/PMC2678141/ /pubmed/19383129 http://dx.doi.org/10.1186/1471-230X-9-26 Text en Copyright ©2009 Bramey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bramey, Thorsten
Freitag, Patricia
Fandrey, Joachim
Rauen, Ursula
Pamp, Katja
Erhard, Jochen
Frede, Stilla
de Groot, Herbert
Petrat, Frank
No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title_full No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title_fullStr No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title_full_unstemmed No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title_short No evidence for protective erythropoietin alpha signalling in rat hepatocytes
title_sort no evidence for protective erythropoietin alpha signalling in rat hepatocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678141/
https://www.ncbi.nlm.nih.gov/pubmed/19383129
http://dx.doi.org/10.1186/1471-230X-9-26
work_keys_str_mv AT brameythorsten noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT freitagpatricia noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT fandreyjoachim noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT rauenursula noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT pampkatja noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT erhardjochen noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT fredestilla noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT degrootherbert noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes
AT petratfrank noevidenceforprotectiveerythropoietinalphasignallinginrathepatocytes